The brutal deaths of George Floyd and Ahmaud Arbery have exposed the country to the systematic racism and injustice that Black Americans face daily. As we reach an inflection point on social injustice, it is time to act on equal access to health … [Read more...]
Telehealth and 340B in the COVID-19 Era and Beyond
May 24, 2020 by
As health centers approach their second quarter of treating patients in the COVID-19 era, one thing is for certain-- telehealth is here to stay. While some of the accommodations that the government has provided may tighten in the post-COVID world, … [Read more...]
The nation’s view of the drug industry and its implications for 340B stakeholders
May 14, 2020 by
As the scientific community continues to devote unprecedented attention and resources to finding treatments and a vaccine for COVID-19, policymakers are wondering whether Americans’ attitudes towards the pharmaceutical industry will change. Last … [Read more...]
Coronavirus likely to sideline 2020 policy changes for prescription pricing and 340B, while Medicare Part B reimbursement changes continue as planned
April 1, 2020 by
The coronavirus (COVID-19) outbreak is not only having a profound impact on our health care system, the American psyche, the stock market and the shelves at Costco — it will also affect what we can expect on drug pricing and 340B … [Read more...]
Time to Step Up Your Efforts at the State Level
January 21, 2020 by
Until recently, 340B program policy was largely debated in Washington, D.C. But as Congress remains stalemated on drug pricing, state capitols have suddenly leapt to the forefront. In this month’s column, I reflect on the … [Read more...]
Pro 340B Grassroots Organization Gains Momentum
December 21, 2019 by
One of the biggest challenges the 340B community has faced over the years is a lack of program knowledge at a local level. As I reported in my May column, Community Voices for 340B (CV340B) is the first grassroots organization solely … [Read more...]
More States Embrace 340B Program as a Win-Win for Taxpayers, Patients and the General Public
November 23, 2019 by
Since I started my column earlier this year, I have written a number of pieces on the unprecedented attention that the 340B program is facing in state capitols. One of the more exciting developments is the growing interest among states to partner … [Read more...]
AIR340B Quietly Steps Up Advocacy Efforts
October 16, 2019 by
For those who have been involved in 340B advocacy for a while, you will likely have heard of AIR340B. The Alliance for Integrity and Reform of 340B (AIR340B) was launched by the pharmaceutical industry in 2013. Its members include the trade … [Read more...]
Hospital specialty pharmacies offer a solution to growing problems: medication access & affordability
August 8, 2019 by
Over the past year, I have learned a lot about specialty pharmacy and its importance to 340B providers and patients. A staggering 65% of the new drugs that came to market in 2018 were specialty drugs. These therapies can improve care and … [Read more...]
President’s Proposal to Require Drug Manufacturers to Disclose Prices in TV Ads
August 7, 2019 by
Ted Slafsky of Wexford Solutions Is Interviewed by Fox News Radio's daily podcast on the President's Proposal to Require Drug Manufacturers to Disclose Prices in TV Ads … [Read more...]